Michael York serves as Executive at PhaseBio Pharmaceuticals Inc, where they oversee executive responsibilities. Since joining the company, Michael York has executed 5 insider transactions totaling $49.7K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 26, 2023 involved selling 107,054 shares valued at $43.9K.
Michael York currently holds 103,499 shares of PhaseBio Pharmaceuticals Inc (PHAS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael York has been a net seller of PHAS stock. They have purchased $5.8K and sold $43.9K worth of shares.
Michael York's most recent insider trade was on Jan 26, 2023, when they sold 107,054 shares at $0.41 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| May 20, 2021 | PHAS | $8.1K | Award | 2,897 | $2.80 | Discretionary |
| Nov 20, 2020 | PHAS | $8.0K | Award | 2,662 | $3.00 | Discretionary |
| Dec 11, 2018 | PHAS | $5.8K | Purchase | 1,500 | $3.88 | Discretionary |